MB-CART20.1 Lymphoma

Clinical trial NCT03664635 · COMPLETED

Trial details

NCT number: NCT03664635
Sponsor: Miltenyi Biomedicine GmbH
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma Non-Hodgkin's Lymphoma B-cell Lymphoma Refractory B-cell Lymphoma Recurrent

Start date: 2018-09-25
Primary completion: 2024-09-17
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.